Open AccessS768 Costs for Treating Patients With Ulcerative Colitis With Vedolizumab or Adalimumab Based on Endoscopic Improvement Data From the VARSITY Trial
Author(s) -
Jesse D. Ortendahl,
Sabyasachi Ghosh,
Ninfa Candela,
Tao Fan,
Kandavadivu Umashankar
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776604.06746.87
Subject(s) - vedolizumab , medicine , ulcerative colitis , colectomy , adalimumab , discontinuation , infliximab , surgery , disease